ArticleScientific reports2016

Targeted in vivo delivery of EGFR siRNA inhibits ovarian cancer growth and enhances drug sensitivity.

Minati Satpathy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.